TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent November 27, 1987
TCL Archive NCI-supported meeting included tobacco industry representatives in dialogue on ethics. October 29, 2004
